Similar Papers

Paper Title
Journal
Date
Author
Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
P Fenaux ... C Buske
Annals of Oncology | VOL. 25
P Fenaux, et. al.P Fenaux ... C Buske
01 Sep 2014
Acute Leukemia
Richard A Larson ... Roland B Walter
DeckerMed Family Medicine | VOL. -
Richard A Larson, et. al.Richard A Larson ... Roland B Walter
28 Jul 2021
Acute Leukemia
Richard A Larson ... Roland B Walter
DeckerMed Transitional Year Weekly Curriculum™ | VOL. -
Richard A Larson, et. al.Richard A Larson ... Roland B Walter
28 Jul 2021
Acute Leukemia
Richard A Larson ... Roland B Walter
DeckerMed Medicine | VOL. -
Richard A Larson, et. al.Richard A Larson ... Roland B Walter
28 Jul 2021
View more papers

More From: American Journal of Hematology

Paper Title
Journal
Date
Author
Recipient Cells Are the Source of Hematologic Malignancies After Graft Failure and Mixed Chimerism in Adults With SCD.
Mohamed A E Ali ... Courtney D Fitzhugh
American journal of hematology | VOL. -
Mohamed A E Ali, et. al.Mohamed A E Ali ... Courtney D Fitzhugh
06 Feb 2025
Multicenter Prospective First-Line Helicobacter Pylori Eradication for Localized Gastric "Pure" Diffuse Large B-Cell Lymphoma.
Li‐Tzong Chen ... Ann‐Lii Cheng
American journal of hematology | VOL. -
Li‐Tzong Chen, et. al.Li‐Tzong Chen ... Ann‐Lii Cheng
06 Feb 2025
Correction to "Secondary-Type Mutations Do Not Impact Prognosis in Acute Myelogenous Leukemia AML With Mutated NPM1".
-
American journal of hematology | VOL. -
--
05 Feb 2025
Differential Clinical and Immunological Impacts of Anti-T-Lymphocyte Globulin (ATLG) vs. Anti-Thymocyte Globulin (ATG) in Preventing Graft-Versus-Host Disease Post-Allogeneic Hematopoietic Stem Cell Transplantation: A Comparative Study.
Anne Beatrice Notarantonio ... Marie Thérèse Rubio
American journal of hematology | VOL. -
Anne Beatrice Notarantonio, et. al.Anne Beatrice Notarantonio ... Marie Thérèse Rubio
04 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.